You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

Details for Patent: 11,027,031

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 11,027,031 protect, and when does it expire?

Patent 11,027,031 protects ILLUCCIX and is included in one NDA.

This patent has forty-two patent family members in eighteen countries.

Summary for Patent: 11,027,031

Title:	Kit for radiolabelling
Abstract:	The present invention relates to a kit for radiolabelling a targeting agent with gallium-68. The present invention also relates to the use of the kit for radiolabelling a targeting agent, and a method for radiolabelling a targeting agent with gallium-68 using the kit.
Inventor(s):	Wouters; Ludovic (Herve, BE), Kaisin; Geoffroy (Seraing, BE), Luxen; Andre (Ocquier-Clavier, BE), Leonard; Marc (Flemalle, BE), Voccia; Samuel (Liege, BE)
Assignee:	ANMI S.A. (Liege, BE)
Application Number:	16/532,526
Patent Claim Types: see list of patent claims	Use; Device;

Drugs Protected by US Patent 11,027,031

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Telix	ILLUCCIX	gallium ga-68 gozetotide	POWDER;INTRAVENOUS	214032-001	Dec 17, 2021		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 11,027,031

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Belgium	2014/0653	Aug 29, 2014

International Family Members for US Patent 11,027,031

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2015309187	⤷ Sign Up
Australia	2015309188	⤷ Sign Up
Australia	2020220193	⤷ Sign Up
Australia	2020220194	⤷ Sign Up
Australia	2022202346	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.